相似文献
1
Joint count reliability in psoriatic arthritis observational trials--an unreported problem.
Rheumatology (Oxford). 2012 Jul;51(7):1333-4. doi: 10.1093/rheumatology/kes095. Epub 2012 May 4.
2
Early psoriatic arthritis.
Rheum Dis Clin North Am. 2012 May;38(2):373-86. doi: 10.1016/j.rdc.2012.05.005. Epub 2012 Jun 29.
3
New drugs for peripheral joint psoriatic arthritis.
Drug Ther Bull. 2006 Jan;44(1):1-5. doi: 10.1136/dtb.2006.4411.
4
Clinical assessment in psoriatic arthritis.
Reumatismo. 2007;59 Suppl 1:68-72. doi: 10.4081/reumatismo.2007.1s.68.
5
A review of disease activity measures for psoriatic arthritis: what is the best approach?
Expert Rev Clin Immunol. 2014 Sep;10(9):1241-54. doi: 10.1586/1744666X.2014.943663. Epub 2014 Aug 4.
6
Spondyloarthritis: Is methotrexate effective in psoriatic arthritis?
Nat Rev Rheumatol. 2012 May 2;8(5):251-2. doi: 10.1038/nrrheum.2012.56.
7
Implementing Psoriatic Arthritis Disease Activity Score-guided treat-to-target in psoriatic arthritis routine clinical practice: (im)possible?
Rheumatology (Oxford). 2019 Dec 1;58(12):2330-2331. doi: 10.1093/rheumatology/kez254.
8
[Psoriatic arthritis: what the dermatologist needs to know, Part 2].
Actas Dermosifiliogr. 2010 Nov;101(9):742-8.
9
Application and modifications of minimal disease activity measures for patients with psoriatic arthritis treated with adalimumab: subanalyses of ADEPT.
J Rheumatol. 2013 May;40(5):647-52. doi: 10.3899/jrheum.120970. Epub 2013 Mar 15.
10
Psoriatic arthritis.
Br J Hosp Med (Lond). 2016 Jul;77(7):C102-8. doi: 10.12968/hmed.2016.77.7.C102.
引用本文的文献
1
Digital biomarkers for psoriatic arthritis: a qualitative focus group study on patient-perceived opportunities and barriers.
RMD Open. 2024 Oct 22;10(4):e004699. doi: 10.1136/rmdopen-2024-004699.
2
Axial Disease in Psoriatic Arthritis study: defining the clinical and radiographic phenotype of psoriatic spondyloarthritis.
Ann Rheum Dis. 2017 Apr;76(4):701-707. doi: 10.1136/annrheumdis-2016-209853. Epub 2016 Dec 2.
本文引用的文献
1
The effectiveness and safety of TNF-alpha blockers in the treatment of early psoriatic arthritis: an Italian multicentre longitudinal observational pilot study.
Clin Rheumatol. 2011 Aug;30(8):1063-7. doi: 10.1007/s10067-011-1680-y. Epub 2011 Mar 1.
2
Prevalence and characteristics of psoriatic arthritis in Chinese patients with psoriasis.
J Eur Acad Dermatol Venereol. 2011 Dec;25(12):1409-14. doi: 10.1111/j.1468-3083.2011.03985.x. Epub 2011 Feb 23.
3
Efficacy and safety of anti-TNF therapies in psoriatic arthritis: an observational study from the British Society for Rheumatology Biologics Register.
Rheumatology (Oxford). 2010 Apr;49(4):697-705. doi: 10.1093/rheumatology/kep423. Epub 2010 Jan 7.
4
International multicenter psoriasis and psoriatic arthritis reliability trial for the assessment of skin, joints, nails, and dactylitis.
Arthritis Rheum. 2009 Sep 15;61(9):1235-42. doi: 10.1002/art.24562.
5
The Swedish early psoriatic arthritis register-- 2-year followup: a comparison with early rheumatoid arthritis.
J Rheumatol. 2008 Apr;35(4):668-73. Epub 2008 Feb 15.
6
Efficacy and tolerability of anti-tumour necrosis factor therapy in psoriatic arthritis patients: results from the South Swedish Arthritis Treatment Group register.
Ann Rheum Dis. 2008 Mar;67(3):364-9. doi: 10.1136/ard.2007.073544. Epub 2007 Jul 20.
7
International spondyloarthritis interobserver reliability exercise--the INSPIRE study: I. Assessment of spinal measures.
J Rheumatol. 2007 Aug;34(8):1733-9. Epub 2007 Jul 1.
8
9
Reliability of measurements of active and damaged joints in psoriatic arthritis.
J Rheumatol. 1990 Jan;17(1):62-4.
Zotero 插件